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Abstract
Background and Objectives: Traumatic brain injury (TBI) is one of the main causes of d
and death worldwide. Sexual steroid hormones have neuroprotective effects on experimental brai
trauma. The purpose of the present study is to explore the effect of the progesterone on br..
edema ,Blood Brain Barrier (BBB) permeability,concentration of NGF and Il,-6 in the serlrm a:.-.
CSF" veterinary coma scale(VCS) and histophatolgic changes (eciema stroma 
.neuronal apopros..
.r,ascular congestion and necrosis).
Methods: The animals were divided intog groups with l4 rats in each group" The groups wcrc .:.
fbllorvs:1)intact proesteros group: rats received no vehicle or drug2)intact non proesteros groLul
rats received no vehicle or drug,3) sham group: oVX rats received no vehicle or drug aq..
underwent false brain trauma under anesthesia.4) TBI group : OVX rats that undernent brair-
traumas. 5) r'ehicle- treated 
-sroup: OVX rats that received progesterone r'ehicle (sesarle oil) ajte'
the TBI. 6) LP-treated group: oVX rats that receir.ed lori'doses of proeesterone (physiologic doses
' 1'7 n-r,e''k-e). 7) HP-treated grottp: O\rX rats that receir,ed high doses of progester-o1..
(pharmacologic doses. 8 mg/kg),8)CP group: oVX rats that implant lorv dose of progesteron;
capsules ( 10-20 ng/ml). 9) Cveh group; OVX rats that impianr vehicle capsules ( 1 0-20 ng/pl)" Ir
groups receiving hormone or vehicle. treatment was administered as a sir-rgle c-lose o-
intraperitoneally 2hours or implant capsules 6 hours following a diffuse TBI that rvas inclucecl br
Marmarou's method. Progesterone. and it's vehicle were purchased frorl Abr-rraihar:
pharmaceuticals (1'ehran, Iran). serum and CSF levels of lL-6 or NGF and WC and EB an.:
histpatholgical changes \\'ere ntezrsured in Sham,TBI.Veh.LP and Hp groups at ,lg hoLrrs ard C-Il
or Cveh groups on 1 r,veek aftelthe TBI.
Results: Findings olcurrent stuc11 dernonstrated that blain edema u'as increased after'fBI ancl thi.
increase was reduced with a lou, or hi-sh doses and capsule of progesterone (respectively. Ir<0.00 i.
P<0'001 and P<0.01) 
"Inaddition" the CSF and serum leveis of NGF and IL-6 rvas increaseci afic:
TBI and this increase in the CSF levels of IL-6 ,,las reduced bl.using Lp, Hp and Cp (respecti'e6.
P<0'001, P<0.001, P<0.01). In aclclition CP and HP caused decrease (respectively. p<0"001an..
P<0'01) in the serum levels of IL-6 after TBL However both doses of progesterone not el.fLct i,.
the serum and CSF levels of NGF but this amount was increased in the CSF (p<L).05) .Hori e-r cr .
Tlie CSF and serum ratio of NGFIIL-6 did not changed after TBI, but LP , HP and CP increasecl
tliis ratio in CSF and serum (respectively,P<0.05, P<0.01, P<0.001and respectively P<0.05 .
P<0.001, P<0.001).furthermore the amount of edema stroma , neuron apoptosis and r,,ascular
,,r1lsestion was lorver in LP group and HP group than that in Veh group (P<0.001) and this amount
.s significant lower in the CP group with Cveh group(P<0.05).Inadditon After low and high doses
rf progesterorre injection and implant of the capsules of progesterone the amount of neuron
..,1ro1.rtosis significantly reduced in compared to veh group (respectively,P<0.01,P<0.001 ancl
P<0.05) . However, in tl-re HP-treated and LP- treated rats the amount of vascular congestion were
iorver (P<0.001) than that in vehicle 
-treated rats and this amount was statistically diff'erent
benveen the CP group and Cveh group (P<0.05). Also after TBI, the neurological score (veterinarl'
conra scale) r,vas significantly higher than vehicle at 4 h after TIll in the group treated with FIP
(P<0.05).
Conclusion: Based on our findings, we conclude that individr-ral measure these two indicators to
evaluate the eft'ects of drugs may be not useful, but CSF NGF/IL-6 ratio might be a better marker
for c'letermine the effectiveness of drug.
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